Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 04 Jun 2026 for Biomarin Pharmaceutical INC. Read the official filing
Filing timeline
BuySaleAthena Countouriotis
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Athena Countouriotis: trading record in brief
Athena Countouriotis, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Biomarin Pharmaceutical Inc, Halozyme Therapeutics, Inc. and Turning Point Therapeutics, Inc. The record holds 10 filings, for trades running from 31 December 2015 to 2 June 2026.
On the market, this insider has only sold: 1 sale, €94k in total. Besides market trades, the filings include 7 share grants and 1 option exercise.
Most recently, on 4 June 2026, the filings show a share grant in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Athena Countouriotis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,490 shares0Common StockSEC:0001628280-26-040922:0
6,650 shares0Common StockSEC:0001048477-25-000066:0
4,720 shares0Common StockSEC:0001048477-24-000096:0
2,180 shares0Common StockSEC:0001048477-23-000068:0
110,959 shares@ US$76.0097.8% of flowCommon StockSEC:0001209191-22-046258:0
2,971 shares@ US$36.301.1% of flowCommon StockSEC:0001209191-22-008979:0
7,500 sharesCommon StockSEC:0001179110-16-017498:0
3,257 sharesCommon StockSEC:0001179110-16-017498:1
15,050 sharesCommon StockSEC:0001179110-16-016968:0
5,655 sharesCommon StockSEC:0001179110-16-016968:1
10 of 10 declarations
